Xencor, Inc. (XNCR)
22.83
-0.02
(-0.09%)
USD |
NASDAQ |
Oct 19, 14:47
Xencor Cash from Operations (Annual) : -135.12M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -135.12M |
| December 31, 2024 | -202.19M |
| December 31, 2023 | 85.11M |
| December 31, 2022 | 24.48M |
| December 31, 2021 | -16.85M |
| December 31, 2020 | -5.004M |
| December 31, 2019 | 64.37M |
| December 31, 2018 | -79.76M |
| Date | Value |
|---|---|
| December 31, 2017 | -33.60M |
| December 31, 2016 | 94.62M |
| December 31, 2015 | 26.67M |
| December 31, 2014 | -21.35M |
| December 31, 2013 | -5.453M |
| December 31, 2012 | -11.05M |
| December 31, 2011 | -1.085M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 127.04M |
| UroGen Pharma Ltd. | -162.44M |
| MeiraGTx Holdings Plc | -46.36M |
| IDEAYA Biosciences, Inc. | -71.10M |
| Iovance Biotherapeutics, Inc. | -302.41M |